The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Anixa Biosciences Inc shares valued at $28,500 were purchased by KUMAR AMIT on Jun 04 ’25. At $2.85 per share, KUMAR AMIT acquired 10,000 shares. The insider’s holdings grew to 569,925 shares worth approximately $2.02 million following the completion of this transaction.
Also, Baskies Arnold M purchased 5,000 shares, netting a total of over 14,100 in proceeds. Following the buying of shares at $2.82 each, the insider now holds 120,000 shares.
Before that, Titterton Lewis H jr had added 2,000 shares to its account. In a trade valued at $5,820, the Director bought Anixa Biosciences Inc shares for $2.91 each. Upon closing the transaction, the insider’s holdings increased to 2,000 shares, worth approximately $3.31 million.
As published in their initiating research note from Maxim Group on March 21, 2025, Anixa Biosciences Inc [ANIX] has been a Buy and the price target has been revised to $10. Analysts at Chardan Capital Markets started covering the stock with ‘”a Buy”‘ outlook in a report released in late December. As of April 12, 2021, H.C. Wainwright has initiated its “Buy” rating for ANIX.
Analyzing ANIX Stock Performance
On last trading session,, Anixa Biosciences Inc [NASDAQ: ANIX] plunged -3.53% to $3.55. During the last five days, there has been a surge of approximately 3.95%. Over the course of the year, Anixa Biosciences Inc shares have jumped approximately 53.02%. Shares of the company reached a 52-week high of $3.80 on 06/18/25 and a 52-week low of $2.07 on 01/14/25.
Support And Resistance Levels for Anixa Biosciences Inc (ANIX)
According to the 24-hour chart, there is a support level at 3.37, which, if violated, would cause prices to drop to 3.20. In the upper region, resistance lies at 3.76. The next price resistance is at 3.98. RSI (Relative Strength Index) is 63.31 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Anixa Biosciences Inc (ANIX)?
In terms of Anixa Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 10 in the next 12 months, up nearly 171.74% from the previous closing price of $3.68. Analysts anticipate Anixa Biosciences Inc stock to reach 10 by 2025, with the lowest price target being 10. In spite of this, 2 analysts ranked Anixa Biosciences Inc stock as Buy at the end of 2025.
